| Long name: |
FITC Conjugated, DRAK2 Polyclonal Antibody |
| Category: |
Conjugated Primary Antibodies |
| Conjugation: |
Anti-FITC Antibody |
| Host Organism: |
Rabbit (Oryctolagus cuniculus) |
| Target Antigen: |
DRAK2 |
| Specificity: |
This is a highly specific antibody against DRAK2 |
| Modification: |
Unmodified |
| Modification site: |
None |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Concentration: |
1ug per 1ul |
| Source: |
KLH conjugated synthetic peptide derived from human DRAK2 |
| Gene ID number: |
9262 |
| Tested applications: |
IF(IHC-P) |
| Recommended dilutions: |
IF(IHC-P)(1:50-200) |
| Crossreactivity: |
Mouse, Rat, Human |
| Crossreactive species details: |
not every possible cross-reactivity is known, Due to limited amount of testing and knowledge |
| Antigen background: |
Certain serine/threonine protein kinases, DRAK2 is located in nucleus and the messenger RNA was ubiquitously expressed in human tissues, DRAKs contain an N terminal kinase domain and a C terminal regulation domain, DRAKs have high sequence homology to DAP and ZIP kinases, Overexpression of DRAK2 induces apoptosis, Two novel serine/threonine kinases that induce apoptosis were recently identified and designated DRAK1 and DRAK2 (for DAP kinase related apoptosis inducing protein kinases), and they represent a novel family of serine/threonine kinases, are mediators of apoptosis, such as ASK1 and RIP, which mediates apoptosis through their catalytic activities, Apoptosis is mediated by death domain containing adapter molecules and a caspase family of proteases |
| Purification method: |
This antibody was purified via Protein A |
| Storage conditions: |
50% glycerol and 0, Store refrigerated at 2 to 8 degrees Celcius for up to 1 year, 09% sodium azide, Keep the antibody in an aqueous buffered solution containing 1% BSA |
| Excitation Emission: |
494nm/518nm |
| Synonyms: |
DRAK2 |
| Properties: |
Bioss Primary Conjugated Antibodies FITC is highly sensitive to pH extremes, FITC has a green emission that's usually collected at 530 nanometers, FITC has a high quantum yield (efficiency of energy transfer from absorption to emission fluorescence) and approximately half of the absorbed photons are emitted as fluorescent light, For fluorescent microscopy applications, This Bioss Primary Conjugated Antibodies Fluorescein isothiocyanate (FITC) antibody is currently after some BD antibodies the most commonly used fluorescent dye for FACS, When excited at 488 nanometers, its photo bleaching effects are not observed due to a very brief interaction at the laser intercept, the 1 FITC is seldom used as it photo bleaches rather quickly though in flow cytometry applications, the FL1 detector of a FACSCalibur or FACScan, C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by Bioss Primary Conjugated Antibodies they should be stored frozen at - 24° |
| Gene target: |
DRAK2 Conjugated |
| Short name: |
FITC Conjugated, DRAK2 Antibody |
| Technique: |
Fluorescein, antibodies against human proteins, antibodies for, antibody Conjugates, Antibody |
| Label: |
FITC |
| Alternative name: |
fluorecein coupled, DRAK2 (Antibody to) |
| Alternative technique: |
antibodies |
| Identity: |
11396 |
| Gene: |
STK17B |
More about : STK17B |
| Long gene name: |
serine/threonine kinase 17b |
| Synonyms gene name: |
serine/threonine kinase 17b (apoptosis-inducing) |
| Synonyms name: |
death-associated protein kinase-related 2 |
| Locus: |
2q32, 3 |
| Discovery year: |
1999-05-21 |
| GenBank acession: |
AB011421 |
| Entrez gene record: |
9262 |
| Pubmed identfication: |
9786912 |
| Classification: |
Death associated protein kinases |
| Havana BLAST/BLAT: |
OTTHUMG00000132735 |